PYRAZINAMIDE , RIFAMPICIN clinical trials

A randomised, prospective phase II study of pharmacokinetics and safety aspects of higher doses of rifampicin and pyrazinamide in a shortened treatment of mild-to-moderate tuberculosis compared with standard of care

This study is looking at new ways to treat mild to moderate tuberculosis (TB). Researchers are testing if higher doses of two existing medicines, rifampicin and pyrazinamide, can make treatment shorter and just as safe as current treatments. This could help people with TB get better faster.